← 홈

황반변성·망막 · TNF-α

6개 · ADC 1048 · Antibody 5323 · CGT 2737 · 다음 갱신 D-13 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 6개
AntibodyJanssenderuxtecan in ovarian cance…Phase 3

infliximab (Remicade, Remicade (infliximab))

Uveitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#인기#항체+5
임상시험 62상태 ACTIVE
AntibodystaleAbbVieApproved

ADA (Adalimumab, Adalimumab (ADA))

Rheumatoid Arthritis · Uveitis

#Uveitis#Antibody#Approved#항체#면역항체+3
효능 ORR 3.6%임상시험 3상태 ACTIVE
AntibodystaleAbbViePhase 2

adalimumab (Humira, Adalimumab plus Methotrexate)

Uveitis · Uveitis

#Uveitis#Antibody#Phase2#항체#면역항체+2
효능 ORR 6.35%임상시험 1상태 ACTIVE
AntibodyAbbVieApproved

adalimumab (Humira, Adalimumab plus different doses of oral glucocorticosteroid)

Uveitis · Uveitis

#Uveitis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAbbViePhase 3

adalimumab (Humira, Adalimumab+Methotrexate)

Uveitis · Uveitis

#Uveitis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleDan LiangPhase 2

adalimumab (Humira, reduction or discontinuation of Adalimumab)

Uveitis; Adalimumab · Uveitis

#Uveitis#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE